Connected Health Limited 31/12/2025 iXBRL

Company registration number: NI616081

Connected Health Limited

Financial statements

31 December 2025

Connected Health Limited

Contents

Directors and other information

Strategic report

Directors report

Independent auditor's report to the members

Statement of comprehensive income

Statement of financial position

Statement of changes in equity

Notes to the financial statements

Connected Health Limited

Directors and other information


	Directors	Douglas Adams
		Ryan Williams


	Secretary	Julie Cordner


	Company number	NI616081


	Registered office	3b Boucher Business Studios
		Glenmachan Place
		Belfast
		BT12 6QH


	Auditor	Hill Vellacott
		Chamber of Commerce House
		22 Great Victoria Street
		Belfast
		BT2 7BA




	Bankers	Ulster Bank
		11 - 16 Donegall Square East
		Belfast
		BT1 5UB

Connected Health Limited

Strategic report

Year ended 31 December 2025

Business review and position

The principal activity of the company is the provision of domiciliary health care services.

The directors are satisfied with the company's performance.

The company operates in a very competitive marketplace and the directors have taken steps to ensure that the company will maintain its competitive strengths and are confident of future results.

Given the nature of the company's activities, the directors are of the opinion that the use of key performance indicators is not necessary for an understanding of the development, performance or position of the company.

Financial risk management objectives and policies

The company has exposure to liquidity risk and customer credit exposure. To a lesser extent the company is exposed to interest rate risk.

The objective of the company in managing liquidity risk is to ensure that it can meet its financial obligations as and when they fall due. The company expects to meet its financial obligations through operating cash flows. In the event that the operating cash flows would not cover all the financial obligations the company will seek additional credit facilities.

This report was approved by the board of directors on 24 September 2026 and signed on behalf of the board by:

Ryan Williams

Director

Connected Health Limited

Directors report

Year ended 31 December 2025

The directors present their report and the financial statements of the company for the year ended 31 December 2025.

Directors

The directors who served the company during the year were as follows:

Douglas Adams

Ryan Williams

Dividends

Particulars of recommended dividends are detailed in note 14 to the financial statements.

Future developments

The directors will continue to develop the business and will seek to take advantage of oppurtunities that arise in the future.

Financial instruments

Details of the financial instruments are provided in the strategic report on page 2.

Directors responsibilities statement

The directors are responsible for preparing the strategic report, directors report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;

- make judgments and accounting estimates that are reasonable and prudent; and

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Auditor

Each of the persons who is a director at the date of approval of this report confirms that:

- so far as they are aware, there is no relevant audit information of which the company's auditor is unaware; and - they have taken all steps that they ought to have taken as a director to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information.

The auditor is deemed to have been re-appointed in accordance with section 487 of the Companies Act 2006.

This report was approved by the board of directors on 24 September 2026 and signed on behalf of the board by:

Ryan Williams

Director

Independent auditor's report to the members of

Connected Health Limited

Year ended 31 December 2025

Opinion

We have audited the financial statements of Connected Health Limited (the 'company') for the year ended 31 December 2025 which comprise the statement of comprehensive income, statement of financial position, statement of changes in equity and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). In our opinion, the financial statements: - give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its profit for the year then ended; - have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and - have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other Information

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

- the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

- the strategic report and the directors' report has been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report. We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: - adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or - the financial statements are not in agreement with the accounting records and the returns; or - certain disclosures of directors' remuneration specified by law are not made; or - we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: Our approach was as follows:We obtained an understanding of the legal and regulatory frameworks that are applicable to the entity and determined that the most significant are those that relate to the Companies Act 2006 and compliance with FRS102; and we assessed the risks of material misstatement in respect of fraud with the consideration of the company's own assessment of the risks that irregularities may occur either because of fraud or error; the results of our enquiries of management about their own identification and assessment of the risks of irregularities; any matters we identified having obtained and reviewed the company's documentation of their policies and procedures relating to identifying, evaluating and complying with laws and regulations and whether they were aware of any instances of non-compliance; detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected or alleged fraud; the internal controls established to mitigate risks of fraud or non-compliance with laws and regulations; and the matters discussed among the audit engagement team regarding how and where fraud might occur in the financial statements and any potential indicators of fraud.Based on the results of our risk assessment we designed our audit procedures to identify non-compliance with such laws and regulations identified above, we considered the opportunities and incentives that may exist within the organisation for fraud and identified the greatest potential for fraud in the areas in which management is required to exercise significant judgment, such as disclosure of adjusting items. In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override; we also obtained an understanding of the legal and regulatory framework that the company operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included UK Companies Act and tax legislation; and in addition, we considered provisions of other laws and regulations that do not have a direct effect on the financial statements but compliance with which may be fundamental to the company's ability to operate or to avoid a material penalty. These included data protection, employment and health and safety regulations.Audit procedures designed to respond to the risks of fraud:We considered the risk of fraud through management override and, in response, we incorporated testing of manual journal entries into our audit approach. We considered the risk of fraud through transactions outside the normal course of transactions by noting anything that was unusual in nature or size and enquired about such transaction to gain an understanding of their nature; based on the results of our risk assessment we designed our audit procedures to identify and to address material misstatements in relation to fraud and other irregularities; extent of audit procedures; and we evaluated the selection and application of accounting policies by the company, particularly those related to subjective measurements and complex transactions, that may be indicative of fraudulent financial reporting. A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditors report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Eoin McMullan (Senior Statutory Auditor)

For and on behalf of

Hill Vellacott

Chartered Accountants

Chamber of Commerce House

22 Great Victoria Street

Belfast

BT2 7BA

24 September 2026

Connected Health Limited

Statement of comprehensive income

Year ended 31 December 2025

		2025	2024
	Note	£	£


Turnover	4	1,136	29,133
Cost of sales		1,127	( 58,400)
		_______	_______
Gross profit/(loss)		2,263	( 29,267)

Administrative expenses		( 3,397,124)	( 2,884,025)
Other operating income	5	41,139	116,422
		_______	_______
Operating loss	6	( 3,353,722)	( 2,796,870)

Income from shares in group undertakings	9	21,000,000	-
Other interest receivable and similar income	10	2,702	( 60,793)
Amounts written off investments	11	-	( 200,000)
Interest payable and similar expenses	12	( 115)	-
		_______	_______
Profit/(loss) before taxation		17,648,865	( 3,057,663)

Tax on profit/(loss)	13	-	-
		_______	_______
Profit/(loss) for the financial year and total comprehensive income		17,648,865	( 3,057,663)
		_______	_______

All the activities of the company are from continuing operations.

Connected Health Limited

Statement of financial position

31 December 2025

		2025		2024
	Note	£	£	£	£

Fixed assets
Intangible assets	15	219,942		257,621
Tangible assets	16	126,213		91,209
Investments	17	5,986,723		5,986,723
		_______		_______
			6,332,878		6,335,553

Current assets
Debtors	18	246,357		138,582
Cash at bank and in hand		312,293		189,919
		_______		_______
		558,650		328,501
Creditors: amounts falling due
within one year	19	( 7,484,429)		( 20,035,820)
		_______		_______
Net current liabilities			( 6,925,779)		( 19,707,319)
			_______		_______
Total assets less current liabilities			( 592,901)		( 13,371,766)

			_______		_______
Net liabilities			( 592,901)		( 13,371,766)
			_______		_______

Capital and reserves
Called up share capital	22		1,273		1,273
Share premium account	23		138,364		138,364
Profit and loss account	23		( 732,538)		( 13,511,403)
			_______		_______
Shareholders deficit			( 592,901)		( 13,371,766)
			_______		_______

These financial statements were approved by the board of directors and authorised for issue on 24 September 2026 , and are signed on behalf of the board by:

Ryan Williams

Director

Company registration number: NI616081

Connected Health Limited

Statement of changes in equity

Year ended 31 December 2025

	Called up share capital	Share premium account	Profit and loss account	Total
	£	£	£	£


At 1 January 2024	1,273	138,364	( 10,453,740)	( 10,314,103)

Profit/(loss) for the year			( 3,057,663)	( 3,057,663)
	_______	_______	_______	_______
Total comprehensive income for the year	-	-	( 3,057,663)	( 3,057,663)

	_______	_______	_______	_______
At 31 December 2024 and 1 January 2025	1,273	138,364	( 13,511,403)	( 13,371,766)

Profit/(loss) for the year			17,648,865	17,648,865
	_______	_______	_______	_______
Total comprehensive income for the year	-	-	17,648,865	17,648,865

Dividends paid and payable			( 4,870,000)	( 4,870,000)
	_______	_______	_______	_______
Total investments by and distributions to owners	-	-	( 4,870,000)	( 4,870,000)

	_______	_______	_______	_______
At 31 December 2025	1,273	138,364	( 732,538)	( 592,901)
	_______	_______	_______	_______

Connected Health Limited

Notes to the financial statements

Year ended 31 December 2025

1. General information

The company is a private company limited by shares, registered in Nothern Ireland. The address of the registered office is Connected Health Limited, 3b Boucher Business Studios, Glenmachan Place, Belfast, BT12 6QH.

2. Statement of compliance

These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Consolidation

The company has taken advantage of the exemption from preparing consolidated financial statements contained in Section 400 of the Companies Act 2006 on the basis that it is a subsidiary undertaking and its immediate parent undertaking is established under the law of any part of the United Kingdom.

The company has not prepared a cash flow statement as this will be included in the consolidated financial statements.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Significant judgementsThere are no judgements (apart from those involving estimations) that management has made in the process of applying the entity's accounting policies and that have the most significant effect on the amounts recognised in the financial statements.Key sources of estimation uncertaintyAccounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome. The key assumptions and other sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are as follows:Impairment of trade debtors is reviewed on an ongoing basis. The company uses estimates based on historical experience and current information in determining the debts for which an impairment charge is required.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

When the outcome of a transaction involving the rendering of services can be reliably estimated, revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period.

When the outcome of a transaction involving the rendering of services cannot be reliably estimated, revenue is recognised only to the extent that it is probable the expenses recognised will be recovered.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Foreign currencies

Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to profit or loss.

Operating leases

Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.

Intangible assets

Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at a revalued amount, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Tangible assets

tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates .

Fixed asset investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

Government grants

Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received. Government grants are recognised using the accrual model and the performance model. Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable. Grants relating to assets are recognised in income on a systematic basis over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income and not deducted from the carrying amount of the asset. Under the performance model, where the grant does not impose specified future performance-related conditions on the recipient, it is recognised in income when the grant proceeds are received or receivable. Where the grant does impose specified future performance-related conditions on the recipient, it is recognised in income only when the performance-related conditions have been met. Where grants received are prior to satisfying the revenue recognition criteria, they are recognised as a liability.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.

4. Turnover

Turnover arises from:

	2025	2024
	£	£
Rendering of services	1,136	29,133
	_______	_______

The whole of the turnover is attributable to the principal activity of the company wholly undertaken in the United Kingdom.

5. Other operating income

	2025	2024
	£	£
Government grant income	41,139	116,302
Other operating income	-	120
	_______	_______
	41,139	116,422
	_______	_______

6. Operating profit/loss

Operating profit/loss is stated after charging/(crediting):

	2025	2024
	£	£
Amortisation of intangible assets	58,982	27,854
Depreciation of tangible assets	61,066	76,983
Impairment of trade debtors	(18,249)	-
Operating lease rentals	-	( 370)
Foreign exchange differences	28,505	3,267
Fees payable for the audit of the financial statements	41,454	21,000
	_______	_______

7. Staff costs

The average number of persons employed by the company during the year, including the directors, amounted to:

	2025	2024
Administrative staff	38	35
Carers	-	2
	_______	_______
	38	37
	_______	_______

The aggregate payroll costs incurred during the year were:

	2025	2024
	£	£
Wages and salaries	1,873,481	1,519,834
Social security costs	233,916	168,759
Other pension costs	206,434	122,343
	_______	_______
	2,313,831	1,810,936
	_______	_______

8. Directors remuneration

The directors aggregate remuneration in respect of qualifying services was:

	2025	2024
	£	£
Remuneration	243,790	183,000
Company contributions to pension schemes in respect of qualifying services	90,433	65,211
	_______	_______
	334,223	248,211
	_______	_______

Remuneration of the highest paid directors in respect of qualifying services:

	2025	2024
	£	£
Aggregate remuneration	130,450	130,000
Company contributions to pension plans in respect of qualifying services	30,433	61,211
	_______	_______
	160,883	191,211
	_______	_______

9. Income from shares in group undertakings

	2025	2024
	£	£
Dividends from shares in group undertakings	21,000,000	(-)
	_______	_______

10. Other interest receivable and similar income

	2025	2024
	£	£
Loans and receivables	454	(60,793)
Other interest receivable and similar income	2,248	-
	_______	_______
	2,702	(60,793)
	_______	_______

11. Amounts written off investments

	2025	2024
	£	£
Impairment of investments in associates	-	200,000
	_______	_______

12. Interest payable and similar expenses

	2025	2024
	£	£
Other interest payable and similar expenses	115	-
	_______	_______

13. Tax on profit/loss

Reconciliation of tax expense

	2025	2024
	£	£
Profit/(loss) before taxation	17,648,865	( 3,057,663)
	_______	_______

Profit/(loss) multiplied by rate of tax	4,412,216	( 764,416)
Effect of expenses not deductible for tax purposes	17,208	63,422
Effect of capital allowances and depreciation	669	( 58,732)
Effect of revenue exempt from tax	( 5,250,000)	-
Utilisation of tax losses	819,907	759,726
	_______	_______
Tax on profit/loss	-	-

14. Dividends

Equity dividends

	2025	2024
	£	£
Dividends paid during the year (excluding those for which a liability existed at the end of the prior year)	4,870,000	-
	_______	_______

15. Intangible assets

	Software Development	Total
	£	£
Cost
At 1 January 2025	285,475	285,475
Additions	21,303	21,303
	_______	_______
At 31 December 2025	306,778	306,778
	_______	_______
Amortisation
At 1 January 2025	27,854	27,854
Charge for the year	58,982	58,982
	_______	_______
At 31 December 2025	86,836	86,836
	_______	_______
Carrying amount
At 31 December 2025	219,942	219,942
	_______	_______
At 31 December 2024	257,621	257,621
	_______	_______

16. Tangible assets

	Fixtures, fittings and equipment	Computer Equipment	Total
	£	£	£
Cost
At 1 January 2025	52,869	294,426	347,295
Additions	73,399	22,671	96,070
	_______	_______	_______
At 31 December 2025	126,268	317,097	443,365
	_______	_______	_______
Depreciation
At 1 January 2025	38,408	217,678	256,086
Charge for the year	14,184	46,882	61,066
	_______	_______	_______
At 31 December 2025	52,592	264,560	317,152
	_______	_______	_______
Carrying amount
At 31 December 2025	73,676	52,537	126,213
	_______	_______	_______
At 31 December 2024	14,461	76,748	91,209
	_______	_______	_______

17. Investments

	Shares in group undertakings	Total
	£	£
Cost
At 1 January 2025 and 31 December 2025	5,986,723	5,986,723
	_______	_______
Impairment
At 1 January 2025 and 31 December 2025	-	-
	_______	_______
Carrying amount
At 31 December 2025	5,986,723	5,986,723
	_______	_______
At 31 December 2024	5,986,723	5,986,723
	_______	_______

Investments in group undertakings
	Registered office	Class of share	Percentage of shares held
Subsidiary undertakings
Connected Health Domiciliary Care Limited	3B Boucher Business Studios, Glenmachan Place, Belfast.	Ordinary	100

Connected Health Ireland Limited	Unit 3, First Floor Block 3, Belgard Road, Tallaght, Dublin 4, DUBLIN, Ireland.	Ordinary	25

IBBSOL Limited	Unit 3, First Floor Block 3, Belgard Road, Tallaght, Dublin 4, DUBLIN, Ireland.	Ordinary	100

Connected Health (Care NI) Limited	3B Boucher Business Studios, Glenmachan Place, Belfast.	Ordinary	100

18. Debtors

	2025	2024
	£	£
Trade debtors	-	7,691
Amounts owed by group undertakings	48,462	-
Prepayments and accrued income	70,977	89,274
Other debtors	126,918	41,617
	_______	_______
	246,357	138,582
	_______	_______

19. Creditors: amounts falling due within one year

	2025	2024
	£	£
Trade creditors	43,423	48,294
Amounts owed to group undertakings	6,884,247	19,353,330
Amounts owed to parent company	257,582	438,348
Accruals and deferred income	167,715	81,454
Corporation tax	-	1,615
Social security and other taxes	103,980	54,971
Other creditors	27,482	57,808
	_______	_______
	7,484,429	20,035,820
	_______	_______

Rbs Invoice Finance Ltd , Laura Adams, Douglas Adams , Douglas Adams and Bernadette Adams as Trustees of the Laura Adams Settlement 2024, Ryan Williams , Scott Christie and BGF Nominees Limited all have a fixed and floating charge over the assets of the company in respect of the total short and long term loan amounts. These are supported by cross guarantee with Connected Health (Care NI) Limited, Connected Health Domiciliary Care Limited, Connected Health Ireland Limited and IBBSOL Ltd. The charge relating to Rbs Invoice Finance Ltd was satisfied post year end.

20. Employee benefits

The amount recognised in profit or loss in relation to defined contribution plans was £ 206,434 (2024: £ 122,343 ).

21. Government grants

The amounts recognised in the financial statements for government grants are as follows:

	2025	2024
	£	£
Recognised in other operating income:
Government grants recognised directly in income	41,139	116,302
	_______	_______

22. Called up share capital

Issued, called up and fully paid

	2025		2024
	No	£	No	£
Ordinary shares of £ 0.25 each	5,090	1,273	5,090	1,273
	_______	_______	_______	_______

23. Reserves

Profit and loss account:This reserve records retained earnings and accumulated losses .

24. Operating leases

The company as lessee

The total future minimum lease payments under non-cancellable operating leases are as follows:


	£	£

Not later than 1 year	213,152	152,312
Later than 1 year and not later than 5 years	478,535	420,649
	_______	_______
	691,687	572,961
	_______	_______

25. Limitation of auditors liability

The company has entered into a liability limitation agreement with the company's auditor which was approved on 29 January 2026. The principal terms of the agreement are that the auditor's liability is limited to a multiple of the audit fee issued and paid for the year, but the multiple cannot be less than such amount as is fair and reasonable.

26. Directors advances, credits and guarantees

	During the year the directors entered into the following advances and credits with the company:

2025
		Balance brought forward	Advances /(credits) to the directors	Balance o/standing
		£	£	£
	Douglas Adams	4,786	671	5,457
		_______	_______	_______

2024
		Balance brought forward	Advances /(credits) to the directors	Balance o/standing
		£	£	£
	Douglas Adams	14,454	( 9,668)	4,786
		_______	_______	_______

27. Related party transactions

Nightingale Bidco Limited owns 100% of the share capital of Connected Health Limited . At the balance sheet date the company owed £3,634,107 (2024: - £14,863,150) to Connected Health Domiciliary Care Limited.At the balance sheet date the company owed £3,250,140 (2024: - £1,969,302) to Connected Health Ireland Limited. At the balance sheet date the company was owed £48,462 (2024: owed to £2,520,878) by Connected Health (Care NI) Limited.At the balance sheet date the company owed £257,582 (2024: £438,348) to Nightingale Bidco Limited.

28. Controlling party

The company is 100% controlled by Nightingale Bidco Limited.